Pharmaceutical Product Development Overview

  • Founded
  • 1985
Founded
  • Status
  • Public
  • Employees
  • 26,000
Employees
  • Stock Symbol
  • PPD
Stock Symbol
  • Investments
  • 27
  • Share Price
  • $46.25
  • (As of Monday Closing)

Pharmaceutical Product Development General Information

Description

PPD is a global contract research organization that provides clinical trial and laboratory services to pharmaceutical, device, and diagnostic firms. The clinical development services segment offers outsourced trial services, spanning early- and late-stage trials, as well as peri- and post-approval trials, and the laboratory services segment includes both advanced lab testing and central lab services. The company was taken private in 2011 and went public again in 2020.. Thermo Fisher Scientific announced it will acquire PPD for $17.4 billion, which is scheduled to close by the end of 2021.

Contact Information

Website
www.ppd.com
Formerly Known As
Eagle Holding Company I
Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
BPO/Outsource Services
Other Industries
Drug Discovery
Biotechnology
Laboratory Services (Healthcare)
Stock Exchange
NAS
Primary Office
  • 929 North Front Street
  • Wilmington, NC 28401-3331
  • United States
+1 (910) 000-0000

Pharmaceutical Product Development Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmaceutical Product Development Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$46.25 $46.20 $22.04 - $46.49 $16.2B 351M 2.92M $0.54

Pharmaceutical Product Development Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 16,978,884 15,650,403
Revenue 4,987,392 4,681,474 4,031,017 3,748,971
EBITDA 757,339 683,596 635,849 669,222
Net Income 215,410 153,691 47,821 104,186
Total Assets 6,467,998 6,293,843 5,556,246 5,489,361
Total Debt 4,422,477 4,451,730 5,843,656 4,795,684
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pharmaceutical Product Development Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pharmaceutical Product Development‘s full profile, request access.

Request a free trial

Pharmaceutical Product Development Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
PPD is a global contract research organization that provides clinical trial and laboratory services to pharmaceutical, d
BPO/Outsource Services
Wilmington, NC
26,000 As of 2020
00.000
00.00 0000-00-00
000000&0 00.000

0000 000

incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ulla
00000 0000000000 00000000
Shanghai, China
00000 As of 0000
00.000
000000000 00.000

000 0000

do consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat
0000000000000 00000000
Raleigh, NC
00000 As of 0000
00000
000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pharmaceutical Product Development Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
WuXi AppTec Formerly PE-Backed Shanghai, China 00000 00.000 000000000 00.000
000 000000 0000000 Formerly PE-Backed Raleigh, NC 00000 00000 000000&0 00000
0000000 0000000000 Formerly PE-Backed Bangalore, India 0000 000.00 00000000000 000.00
000000 00000000 Corporation Moscow, Russia 000
000000000 Formerly PE-Backed Morrisville, NC 000 00000 000000&0 00000
You’re viewing 5 of 31 competitors. Get the full list »

Pharmaceutical Product Development Executive Team (40)

Name Title Board Seat Contact Info
David Simmons Chief Executive Officer & Chairman
Christopher Scully Executive Vice President & Chief Financial Officer
William Sharbaugh Chief Operating Officer, Operations
Rob Petrie Senior Vice President & Chief Technology Officer
Glen Donovan Chief Accounting Officer, Accounting
You’re viewing 5 of 40 executive team members. Get the full list »

Pharmaceutical Product Development Board Members (14)

Name Representing Role Since
00000 000000 Hellman & Friedman Board Member 000 0000
00000 0000 Self Board Member 000 0000
00000 0000000 Pharmaceutical Product Development Chief Executive Officer & Chairman 000 0000
000000 000000000 Hellman & Friedman Board Member 000 0000
0000000 0000000 00 Self Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Pharmaceutical Product Development Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pharmaceutical Product Development Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pharmaceutical Product Development‘s full profile, request access.

Request a free trial

Pharmaceutical Product Development Investments & Acquisitions (27)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 15-Apr-2021 00000 00000 00 00000 Outcome Management (Healthcare)
0000000 00 20-Aug-2020 00000 00000 00 0000 Other Healthcare Services 0000000 00 00000
0000000 28-Apr-2020 00000 00000 00 000.00 Outcome Management (Healthcare)
0000000 00 05-Mar-2019 00000 00000 00 0000 Other Healthcare Services 0000000 00 00000
Evidera 16-Aug-2016 Buyout/LBO Consulting Services (B2B) 00000 0000000
You’re viewing 5 of 27 investments and acquisitions. Get the full list »

Pharmaceutical Product Development Subsidiaries (3)

Company Name Industry Location Founded
Evidera Consulting Services (B2B) Bethesda, MD 2013
00000 000000000000 Laboratory Services (Healthcare) Beijing, China 0000
0000000 Application Software Horsham, PA 0000
To view Pharmaceutical Product Development’s complete subsidiaries history, request access »

Pharmaceutical Product Development Exits (12)

Company Name Exit Date Exit Type Exit Size Status Buyers
0-0000 25-Sep-2014 000000000 0000 Completed
  • 00000000000000 000
0-00 04-Jan-2013 00000 00000 00 00.00 Completed
  • 00000000000000 000
0000000000 13-Jun-2012 00000 00000 00 00.00 Completed
  • 7 buyers
000000 00000000000 01-Dec-2010 00000 00000 00 00.00 Completed
  • 7 buyers
X-Chem 01-Oct-2010 Merger/Acquisition 000.00 Completed
You’re viewing 5 of 12 exits. Get the full list »